Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein